Roche’s Next Front For Innovation: Reimbursement
Executive Summary
Roche is preparing for the ripple effects of its burgeoning oncology pipeline by trying to innovate on reimbursement models as well. But indication-based and outcome-based pricing are still “a long ways off,” COO O’Day says.